官方服务：
资源简介：
images of multiplex IHC staining of MMTV-PyMT mammary carcinoma tissue three days after local Venetoclax drug delivery
应用场景：
创建时间：
2022-05-05
相关数据集
Combination Chemotherapy With or Without Cetuximab in Treating Patients With Stage III Colon Cancer That Was Completely Removed By Surgery
RATIONALE: Drugs used in chemotherapy, such as oxaliplatin, leucovorin, or fluorouracil, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from
NIAID Data Ecosystem70
A 46-year old women with DFSP at paravertebral site at the level of L3–4 and RUL zone of chest.
Lumbar spine MRI and chest CT were taken. A, before initiation of treatment with imatinib. B, after 4 months treatment with imatinib. C, after further 2 months treatment with imatinib and 3 months tre
NIAID Data Ecosystem50
Efficacy and safety of vemurafenib in Langerhans cell histiocytosis (LCH): A systematic review and meta-analysis
Almost half of the patients with Langerhans cell histiocytosis (LCH) are refractory to primary induction chemotherapy or undergo reactivation. The ideal treatment modality for refractory/relapsed LCH
Taylor & Francis Group2023-01-26 更新30
Table_1_Efficacy of Vandetanib in Treating Locally Advanced or Metastatic Medullary Thyroid Carcinoma According to RECIST Criteria: A Systematic Review and Meta-Analysis.docx
BackgroundVandetanib is the most largely used tyrosine kinase inhibitor (TKI) in patients with locally advanced and/or metastatic medullary thyroid cancer (MTC). Here, we conducted a systematic review
NIAID Data Ecosystem70
PIK3CA as a therapeutic target for patients with proliferative glomerulonephritis. PIK3CA as a therapeutic target for patients with proliferative glomerulonephritis
Proliferative glomerulonephritis is a severe kidney condition often associated with advanced renal failure. Unfortunately, there is a significant lack of effective treatment options for these disorder
NIAID Data Ecosystem50
